A Gecko-Derived Peptide Gel That Protects Skin from UV-Induced Aging in Mice

Researchers formulated the gecko-derived peptide G3CY-10 into a microemulsion gel using a lecithin-ethanol-butyl acetate system and tested its stability and transdermal delivery efficiency. They then exposed mice to UV radiation to induce photoaging and applied the peptide gel topically. Outcomes were assessed by measuring epidermal thickness, sebaceous gland proliferation, collagen fiber density (via Masson staining), collagen degradation markers, and superoxide dismutase levels.

Getting peptides through the skin barrier is one of the biggest challenges in topical peptide therapy — most peptides are too large to penetrate effectively. This study tackles that problem with a microemulsion gel system that significantly improves skin penetration. The fact that a gecko-derived cathelicidin shows anti-photoaging effects (not just antimicrobial activity) expands our understanding of what cathelicidin peptides can do, while the delivery system could potentially be applied to other therapeutic peptides.

Cathelicidins are best known as antimicrobial peptides — part of the body's innate immune defense. Finding anti-aging properties in a gecko-derived cathelicidin highlights the surprising versatility of this peptide family. Meanwhile, the microemulsion gel delivery system addresses a major bottleneck in topical peptide therapy. As the cosmetic and pharmaceutical industries increasingly look to bioactive peptides, effective skin delivery systems like this one could unlock a new generation of topical peptide products.

This is a mouse study — human skin structure and thickness differ significantly from murine skin, which may affect transdermal delivery results. The study does not report long-term safety data for the peptide or the microemulsion vehicle. No comparison was made against established anti-photoaging treatments like retinoids or vitamin C. The specific UV exposure protocol may not fully replicate natural sun exposure patterns.